Madrigal Pharmaceuticals Inc (MDGL)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$509.76

Buy

$520.00

arrow-down$-3.67 (-0.71%)

Prices updated at 25 Jun 2026, 00:38 EDT

Prices minimum 15 mins delay

Prices in USD

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver fa ...

NASDAQ

-0.43%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

	$527.71 - $509.07
	$615.00 - $277.64
	-
	11,837.47m
	-
	-
	399,806
	21.78
	348,187.40
	1.33
	22.84m
	US5588681057
	-13.49
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.